Congress Wealth Management LLC DE Buys 34 Shares of HCA Healthcare, Inc. (NYSE:HCA)

Congress Wealth Management LLC DE raised its position in shares of HCA Healthcare, Inc. (NYSE:HCA) by 3.4% in the fourth quarter, HoldingsChannel.com reports. The firm owned 1,039 shares of the company’s stock after purchasing an additional 34 shares during the quarter. Congress Wealth Management LLC DE’s holdings in HCA Healthcare were worth $312,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of HCA. MML Investors Services LLC lifted its holdings in HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after buying an additional 4,285 shares during the period. Meritage Group LP bought a new stake in shares of HCA Healthcare during the 3rd quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC acquired a new position in HCA Healthcare in the fourth quarter valued at approximately $18,044,000. NRI Wealth Management LC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth approximately $2,896,000. Finally, Czech National Bank boosted its stake in HCA Healthcare by 4.5% during the fourth quarter. Czech National Bank now owns 39,543 shares of the company’s stock worth $11,869,000 after acquiring an additional 1,691 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Buying and Selling

In other HCA Healthcare news, SVP Jennifer Berres sold 9,533 shares of the firm’s stock in a transaction dated Friday, February 14th. The stock was sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This trade represents a 38.22 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 1.30% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms have recently issued reports on HCA. Royal Bank of Canada cut their price objective on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a research report on Monday, January 27th. JPMorgan Chase & Co. restated a “neutral” rating and set a $380.00 price objective on shares of HCA Healthcare in a report on Tuesday, December 17th. Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 target price on shares of HCA Healthcare in a report on Monday, January 27th. Truist Financial lowered their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Finally, Bank of America decreased their price target on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $385.67.

HCA Healthcare Stock Down 0.0 %

HCA opened at $342.25 on Friday. The company has a 50 day moving average of $324.53 and a 200 day moving average of $341.25. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a market cap of $84.26 billion, a PE ratio of 15.58, a price-to-earnings-growth ratio of 1.10 and a beta of 1.68.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the business posted $5.90 EPS. On average, sell-side analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a $0.72 dividend. This represents a $2.88 annualized dividend and a yield of 0.84%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio (DPR) is presently 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.